Trilogy Writing and Consulting Logo

Navigating the Global Transparency Landscape

January 24, 2019 | North Carolina, US

Trilogy hosted a discussion on the implications that the disclosure and transparency regulations will have on producing clinical regulatory documentation and provided insight from an actual anonymization procedure, together with our speakers:

  • Jo Anne-Marie Blyskal (Head of Global Regulatory Medical Writing and Data Disclosure, Teva)
  • Dr. Julia Forjanic Klapproth (Senior Partner, President at Trilogy Writing & Consulting)